BMEZ · BlackRock Health Sciences Term Trust · Fund Holdings
Market Cap
$1.06B
Shares
62.50M
Volume · Oct 5
134.81K
Avg daily vol (3M)
143.43K
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
BlackRock Health Sciences Term Trust
Reported 2026-06-30Net Assets
$1,077,270,525
Total Assets
$1,085,594,062
Holdings
175
Filed
2026-08-25
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| Moderna Inc | 60770K107 | 549,814 | NS | $38,503,474 | 3.57% | EC | US |
| Johnson & Johnson | 478160104 | 145,639 | NS | $36,987,937 | 3.43% | EC | US |
| Merck & Co Inc | 58933Y105 | 252,501 | NS | $32,446,379 | 3.01% | EC | US |
| Biogen Inc | 09062X103 | 137,487 | NS | $29,705,441 | 2.76% | EC | US |
| PsiQuantum Corp | 000000000 | 571,947 | NS | $27,619,321 | 2.56% | EC | US |
| Gilead Sciences Inc | 375558103 | 214,745 | NS | $27,130,883 | 2.52% | EC | US |
| Edwards Lifesciences Corp | 28176E108 | 277,879 | NS | $25,136,934 | 2.33% | EC | US |
| Neurocrine Biosciences Inc | 64125C109 | 127,517 | NS | $21,491,078 | 1.99% | EC | US |
| Novartis AG | 000000000 | 136,779 | NS | $21,377,505 | 1.98% | EC | CH |
| Amgen Inc | 031162100 | 57,154 | NS | $20,696,606 | 1.92% | EC | US |
| Illumina Inc | 452327109 | 116,338 | NS | $20,455,711 | 1.90% | EC | US |
| Roche Holding AG | 000000000 | 46,443 | NS | $19,092,079 | 1.77% | EC | CH |
| Thermo Fisher Scientific Inc | 883556102 | 34,802 | NS | $17,448,331 | 1.62% | EC | US |
| AbbVie Inc | 00287Y109 | 67,970 | NS | $17,103,971 | 1.59% | EC | US |
| Genmab A/S | 000000000 | 58,159 | NS | $15,944,419 | 1.48% | EC | DK |
| Axsome Therapeutics Inc | 05464T104 | 62,902 | NS | $15,396,523 | 1.43% | EC | US |
| Danaher Corp | 235851102 | 79,322 | NS | $15,109,255 | 1.40% | EC | US |
| Agilent Technologies Inc | 00846U101 | 112,566 | NS | $14,952,142 | 1.39% | EC | US |
| Natera Inc | 632307104 | 52,122 | NS | $14,148,517 | 1.31% | EC | US |
| BlackRock Liquidity Funds | 09248U718 | 13,962,826 | NS | $13,962,826 | 1.30% | STIV | US |
| Cytokinetics Inc | 23282W605 | 162,568 | NS | $13,849,168 | 1.29% | EC | US |
| Charles River Laboratories International Inc | 159864107 | 60,883 | NS | $13,807,656 | 1.28% | EC | US |
| UnitedHealth Group Inc | 91324P102 | 32,974 | NS | $13,704,984 | 1.27% | EC | US |
| GSK PLC | 000000000 | 521,765 | NS | $13,697,832 | 1.27% | EC | GB |
| Guardant Health Inc | 40131M109 | 89,770 | NS | $13,468,193 | 1.25% | EC | US |
| UCB SA | 000000000 | 44,287 | NS | $13,258,246 | 1.23% | EC | BE |
| Revolution Medicines Inc | 76155X100 | 69,377 | NS | $12,992,925 | 1.21% | EC | US |
| Sartorius AG | 000000000 | 47,229 | NS | $12,390,459 | 1.15% | EP | DE |
| ADARX PHARMACEUTICALS INC | 000000000 | 860,577 | NS | $12,185,770 | 1.13% | EC | US |
| Bio-Techne Corp | 09073M104 | 169,594 | NS | $11,981,816 | 1.11% | EC | US |
| Dexcom Inc | 252131107 | 173,259 | NS | $11,668,994 | 1.08% | EC | US |
| Exelixis Inc | 30161Q104 | 210,176 | NS | $11,435,676 | 1.06% | EC | US |
| Immunocore Holdings PLC | 45258D105 | 359,126 | NS | $11,402,251 | 1.06% | EC | GB |
| Rhythm Pharmaceuticals Inc | 76243J105 | 101,573 | NS | $11,277,650 | 1.05% | EC | US |
| Argenx SE | 04016X101 | 11,933 | NS | $11,071,079 | 1.03% | EC | NL |
| AstraZeneca PLC | 000000000 | 57,869 | NS | $10,973,120 | 1.02% | EC | GB |
| Pfizer Inc | 717081103 | 441,187 | NS | $10,623,783 | 0.99% | EC | US |
| Vertex Pharmaceuticals Inc | 92532F100 | 20,900 | NS | $10,381,657 | 0.96% | EC | US |
| Bristol-Myers Squibb Co | 110122108 | 177,819 | NS | $10,245,931 | 0.95% | EC | US |
| Boston Scientific Corp | 101137107 | 239,074 | NS | $10,203,678 | 0.95% | EC | US |
| GENESIS THERAPEUTICS INC | 000000000 | 1,370,506 | NS | $10,128,039 | 0.94% | EC | US |
| IQVIA Holdings Inc | 46266C105 | 46,747 | NS | $9,032,455 | 0.84% | EC | US |
| Alkermes PLC | 000000000 | 166,685 | NS | $8,733,461 | 0.81% | EC | IE |
| Cogent Biosciences Inc | 19240Q201 | 221,514 | NS | $8,572,592 | 0.80% | EC | US |
| Roivant Sciences Ltd | 000000000 | 240,456 | NS | $8,509,738 | 0.79% | EC | BM |
| Protagonist Therapeutics Inc | 74366E102 | 68,855 | NS | $8,440,246 | 0.78% | EC | US |
| Lonza Group AG | 000000000 | 12,000 | NS | $8,095,249 | 0.75% | EC | CH |
| LARONDE INC | 000000000 | 482,077 | NS | $8,045,865 | 0.75% | EC | US |
| NUMAB THERAPEUTICS AG | 000000000 | 1,139,305 | NS | $8,037,176 | 0.75% | EC | CH |
| Eisai Co Ltd | 000000000 | 304,900 | NS | $7,685,994 | 0.71% | EC | JP |
Showing 1–50 of 175 holdings
Key facts
CIK
1785971
CUSIP
09260E105